Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies
Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This is the first study to test Sym015 in humans. The primary purpose of this study is to see
if Sym015 is safe and effective for patients with advanced solid tumor malignancies without
available therapeutic options.